Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 536591, 8 pages
http://dx.doi.org/10.1155/2014/536591
Research Article

Computational Analysis of mRNA Expression Profiles Identifies the ITG Family and PIK3R3 as Crucial Genes for Regulating Triple Negative Breast Cancer Cell Migration

1Department of Clinical Pharmacy, Taipei Medical University, Taipei 110, Taiwan
2Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
3Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 106, Taiwan
4Cathay General Hospital SiJhih, New Taipei 221, Taiwan
5School of Medicine, Fu-Jen Catholic University, New Taipei 242, Taiwan
6School of Medicine, Taipei Medical University, Taipei 110, Taiwan
7Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
8Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
9Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan
10Department of Pharmacy, Taipei Medical University-Wan Fang Hospital, Taipei 116, Taiwan
11Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei 110, Taiwan

Received 26 November 2013; Accepted 18 March 2014; Published 6 May 2014

Academic Editor: Dongquan Shi

Copyright © 2014 Sukhontip Klahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Carey, E. Winer, G. Viale, D. Cameron, and L. Gianni, “Triple-negative breast cancer: disease entity or title of convenience?” Nature Reviews Clinical Oncology, vol. 7, no. 12, pp. 683–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Brouckaert, H. Wildiers, G. Floris, and P. Neven, “Update on triple-negative breast cancer: prognosis and management strategies,” International Journal of Women's Health, vol. 4, pp. 511–520, 2012. View at Google Scholar
  4. F. Heitz, P. Harter, A. Traut, H. J. Lueck, B. Beutel, and A. du Bois, “Cerebral metastases (CM) in breast cancer (BC) with focus on triple-negative tumors,” Journal of Clinical Oncology, vol. 26, no. 15, supplement, 2008. View at Google Scholar
  5. T. O. Nielsen, F. D. Hsu, K. Jensen et al., “Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma,” Clinical Cancer Research, vol. 10, no. 16, pp. 5367–5374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Tseng, N. C. Hsu, S. C. Chen et al., “Distant metastasis in triple-negative breast cancer,” Neoplasma, vol. 60, no. 3, pp. 290–294, 2013. View at Publisher · View at Google Scholar
  7. R. Dent, M. Trudeau, K. I. Pritchard et al., “Triple-negative breast cancer: clinical features and patterns of recurrence,” Clinical Cancer Research, vol. 13, no. 15, part 1, pp. 4429–4434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Dent, W. M. Hanna, M. Trudeau, E. Rawlinson, P. Sun, and S. A. Narod, “Pattern of metastatic spread in triple-negative breast cancer,” Breast Cancer Research and Treatment, vol. 115, no. 2, pp. 423–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. G. Haffty, Q. Yang, M. Reiss et al., “Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer,” Journal of Clinical Oncology, vol. 24, no. 36, pp. 5652–5657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kennecke, R. Yerushalmi, R. Woods et al., “Metastatic behavior of breast cancer subtypes,” Journal of Clinical Oncology, vol. 28, no. 20, pp. 3271–3277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. J. Morris, S. Naidu, A. K. Topham et al., “Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer institute's surveillance, epidemiology, and end results database,” Cancer, vol. 110, no. 4, pp. 876–884, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. U. Lin, A. Vanderplas, M. E. Hughes et al., “Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network,” Cancer, vol. 118, no. 22, pp. 5463–5472, 2012. View at Google Scholar
  13. K. Yao-Lung, C. Dar-Ren, and C. Tsai-Wang, “Clinicopathological features of triple-negative breast cancer in Taiwanese women,” International Journal of Clinical Oncology, vol. 16, no. 5, pp. 500–505, 2011. View at Google Scholar · View at Scopus
  14. C. Y. Li, S. Zhang, X. B. Zhang, P. Wang, G. F. Hou, and J. Zhang, “Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 6, pp. 3779–3784, 2013. View at Google Scholar
  15. K. Zygourakis, “Quantification and regulation of cell migration,” Tissue Engineering, vol. 2, no. 1, pp. 1–16, 1996. View at Google Scholar · View at Scopus
  16. J. Jouanneau, S. Bellusci, G. Moens, and J. P. Thiery, “Molecular aspects of invasiveness and metastasis,” Pathologie Biologie, vol. 43, no. 3, pp. 181–187, 1995. View at Google Scholar · View at Scopus
  17. R. Lindner, C. Sullivan, O. Offor et al., “Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy,” PLoS ONE, vol. 8, no. 11, Article ID e71915, 2013. View at Google Scholar
  18. W. H. Kuo, Y. Y. Chang, L. C. Lai et al., “Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas,” PLoS ONE, vol. 7, no. 9, Article ID e45831, 2012. View at Google Scholar
  19. “Whole-genome DASL HT assay for expression profiling in ffpe samples,” http://res.illumina.com/documents/products/datasheets/datasheet_whole_genome_dasl.pdf.
  20. “Agilent whole human genome oligo microarray kit,” http://www.chem.agilent.com/library/brochures/5989_0654en_wghuman_7_04_web.pdf.
  21. American Joint Commitee on Cancer, https://cancerstaging.org.
  22. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Castellana, D. Escuin, G. Peiro et al., “ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas,” Journal of Cancer, vol. 3, pp. 175–183, 2012. View at Publisher · View at Google Scholar
  25. M. T. Epping, L. Wang, M. J. Edel, L. Carlée, M. Hernandez, and R. Bernards, “The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling,” Cell, vol. 122, no. 6, pp. 835–847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Rodriguez-Mari, C. Canestro, R. A. BreMiller, J. M. Catchen, Y. L. Yan, and J. H. Postlethwait, “Retinoic acid metabolic genes, meiosis, and gonadal sex differentiation in zebrafish,” PLoS ONE, vol. 8, no. 9, Article ID e73951, 2013. View at Google Scholar
  27. I. A. Ivanova, J. F. Vermeulen, C. Ercan et al., “FER kinase promotes breast cancer metastasis by regulating alpha6- and beta1-integrin-dependent cell adhesion and anoikis resistance,” Oncogene, vol. 32, no. 50, pp. 5582–5592, 2013. View at Google Scholar
  28. D. Barkan and A. F. Chambers, “β1-integrin: a potential therapeutic target in the battle against cancer recurrence,” Clinical Cancer Research, vol. 17, no. 23, pp. 7219–7223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Sredni, “Immunomodulating tellurium compounds as anti-cancer agents,” Seminars in Cancer Biology, vol. 22, no. 1, pp. 60–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Velasco-Velázquez, N. Salinas-Jazmín, N. Mendoza-Patiño, and J. J. Mandoki, “Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells,” Cancer Cell International, vol. 8, article 8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. G. J. Mizejewski, “Role of integrins in cancer: survey of expression patterns,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 2, pp. 124–138, 1999. View at Google Scholar · View at Scopus
  32. E. Nagore, A. Montoro, Z. García-Casado et al., “Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer,” Melanoma Research, vol. 19, no. 4, pp. 211–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. A. El-Attar and M. I. Sheta, “Hepatocyte growth factor profile with breast cancer,” Indian Journal of Pathology and Microbiology, vol. 54, no. 3, pp. 509–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-M. Sheen-Chen, Y.-W. Liu, H.-L. Eng, and F.-F. Chou, “Serum levels of hepatocyte growth factor in patients with breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 3, pp. 715–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Kramer, J. Green, J. Pollard Jr., and S. Tugendreich, “Causal analysis approaches in ingenuity pathway analysis,” Bioinformatics, vol. 30, pp. 523–530, 2014. View at Google Scholar
  36. L. Xu, Z. Wen, Y. Zhou et al., “MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway,” Molecular Biology of the Cell, vol. 24, no. 1, pp. 42–55, 2013. View at Google Scholar
  37. X. Kong, G. Li, Y. Yuan et al., “MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression,” PLoS ONE, vol. 7, no. 8, Article ID e41523, 2012. View at Google Scholar
  38. S. Hyun, J. H. Lee, H. Jin et al., “Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K,” Cell, vol. 139, no. 6, pp. 1096–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. H. Ausprunk and J. Folkman, “Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis,” Microvascular Research, vol. 14, no. 1, pp. 53–65, 1977. View at Google Scholar · View at Scopus